Sherman Kenneth E, Sherman Susan N, Chenier Thomas, Tsevat Joel
Hepatology and Liver Transplant Medicine Section, Division of Digestive Diseases, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0595, USA.
Arch Intern Med. 2004 Nov 22;164(21):2377-82. doi: 10.1001/archinte.164.21.2377.
Patients with hepatitis C virus (HCV) infection report a reduction in health status, but it is not known how they value their state of health. We assessed health utilities directly from patients with HCV infection.
One hundred twenty-four patients with chronic HCV infection representing a cross section of disease severity were administered a disease-specific version of the Medical Outcomes Study 36-Item Short-Form Health Survey, the Beck Depression Inventory, and 3 direct health value measures, including the Rating Scale, Time Trade-off (TTO), and Standard Gamble (SG). Correlation among measures and factor analysis was performed.
The mean modified Medical Outcomes Study 36-Item Short-Form Health Survey scores were lower than normative population values, particularly on the Physical Component Summary scale. This scale was poorly correlated with the Rating Scale, TTO, and SG scores among HCV-infected subjects. The mean +/- SE TTO score was 0.83 +/- 0.02, and the mean +/- SE SG score was 0.79 +/- 0.02. The TTO and SG scores failed to show significant variability in relation to disease activity as determined by serum alanine aminotransferase level, histologic stage, and presence of decompensated liver disease. The Beck Depression Inventory was significantly inversely correlated with the TTO and SG.
Although quality of life is compromised in patients with chronic HCV infection, patient-derived health utilities are not strongly associated with health status or clinical measures. Utility measures obtained from patients with HCV differ significantly from previous surrogate measures of health values. Such differences in utilities could affect decision analyses and cost-effectiveness analyses of treatment interventions for individuals with HCV infection.
丙型肝炎病毒(HCV)感染患者报告其健康状况有所下降,但尚不清楚他们如何评价自身的健康状态。我们直接评估了HCV感染患者的健康效用。
对124例代表不同疾病严重程度的慢性HCV感染患者进行了特定疾病版本的医学结局研究36项简短健康调查、贝克抑郁量表以及3种直接健康价值测量方法,包括等级量表、时间权衡法(TTO)和标准博弈法(SG)。进行了测量方法之间的相关性分析和因子分析。
改良后的医学结局研究36项简短健康调查的平均得分低于正常人群值,尤其是在生理健康综合量表上。在HCV感染受试者中,该量表与等级量表、TTO和SG得分的相关性较差。TTO得分的均值±标准误为0.83±0.02,SG得分的均值±标准误为0.79±0.02。根据血清丙氨酸氨基转移酶水平、组织学分期和失代偿性肝病的存在情况确定,TTO和SG得分在疾病活动方面未显示出显著差异。贝克抑郁量表与TTO和SG呈显著负相关。
尽管慢性HCV感染患者的生活质量受到损害,但患者得出的健康效用与健康状况或临床指标并无密切关联。从HCV感染患者获得的效用测量方法与先前的健康价值替代测量方法有显著差异。这些效用差异可能会影响对HCV感染个体治疗干预措施的决策分析和成本效益分析。